Showing results (1-10 of 148) with videos related to
Sort By:
Pageof 15
Tumori|June 13, 2001
High throughput HLA sequence-based typing (SBT) utilizing the ABI Prism 3700 DNA AnalyzerS D Adams, K C Barracchini, T B Simonis, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 21, 1999
High-resolution HLA-A*0201 subtyping using directed heteroduplex analysisE J Kicklighter, K H Lee, K C Barracchini, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: relevance for epitope specific vaccination protocolsM A Player, K C Barracchini, T B Simonis, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2000
Frequency of human leukocyte antigen-A 24 alleles in patients with melanoma determined by human leukocyte antigen-A sequence-based typingM P Bettinotti, R D Norris, J A Hackett, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1996
Combination therapy with interferon-gamma and interleukin-2 for the treatment of metastatic melanomaC J Kim, J K Taubenberger, T B Simonis, et al.The Cancer Journal From Scientific American|January 1, 1997
Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan AJ N Cormier, M L Salgaller, T Prevette, et al.Cancer Research|July 15, 1995
Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytesL Rivoltini, K C Barracchini, V Viggiano, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1994
Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell linesF M Marincola, P Shamamian, T B Simonis, et al.Cancer Research|December 1, 1992
HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapyF M Marincola, D Venzon, D White, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 5, 2002
Laser scanning cytometry evaluation of MART-1, gp100, and HLA-A2 expression in melanoma metastasesS Mocellin, P Fetsch, A Abati, et al.Pageof 15